A phase 3 study of eftilagimod alfa for NSCLC is ending early due to futility, according to an update from developer Immutep.

By Phil Stewart, Idrees Ali, Erin Banco and Gram SlatteryWASHINGTON, March 18 (Reuters) - President Donald Trump's ...

Running for Clean Air' expands to three continents, five events in two years, as one of the most comprehensive athlete health and air quality monitoring programmes in athletics. World Athletics today ...

VITA launches VITA RING on Kickstarter, introducing a "second phase" of smart rings that shifts from passive tracking ...

US Central Command (CENTCOM) has plans to prevent Iran’s remaining enriched uranium from being weaponized by remnants of the regime, Defense Secretary Pete Hegseth suggested.

Blinded safety data from the ongoing Phase 2 trial suggest no treatment-related amyloid-related imaging abnormalities (ARIA) with PRI-002 Drug Safety and Monitoring Board recommended continued ...

DM End-to-End uses AI to connect observation, treatment, and retention with a new cap fee for total cost transparency ...

Digital law is entering a new phase. As smart contracts and AI reshape legal workflows, the real challenge is no longer ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

Piermont Bank expanded its leadership team to scale its embedded banking platform and deepen its support for growing businesses operating ...

TITUSVILLE, Fla. - Titusville officials have launched a new speed enforcement program to cut down on drivers speeding in ...

The Union government on Monday urged consumers not to panic over LPG supplies and warned against hoarding and black marketing ...